| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |